Treatment of Non-neovascular Idiopathic Macular Telangiectasia Type 2 with Intravitreal Ranibizumab: Results of a Phase II Clinical Trial

PURPOSE: To evaluate the safety and preliminary efficacy of intravitreal ranibizumab for non-neovascular idiopathic macular telangiectasia, type 2 (IMT2). METHODS: Single-center, open-label phase II clinical trial enrolling 5 participants with bilateral non-neovascular IMT2. Intravitreal ranibizumab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Retina
Main Authors: Toy, Brian C., Koo, Euna, Cukras, Catherine, Meyerle, Catherine B., Chew, Emily Y., Wong, Wai T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4696751/
https://ncbi.nlm.nih.gov/pubmed/22266930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0b013e31824690a8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados